- Home
- CRVO vs RDZN Comparison
CRVO vs RDZN Comparison
Compare CRVO & RDZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVO
- RDZN
- Stock Information
- Founded
- CRVO 2001
- RDZN 2015
- Country
- CRVO United States
- RDZN United States
- Employees
- CRVO N/A
- RDZN N/A
- Industry
- CRVO Biotechnology: Pharmaceutical Preparations
- RDZN Blank Checks
- Sector
- CRVO Health Care
- RDZN Finance
- Exchange
- CRVO Nasdaq
- RDZN Nasdaq
- Market Cap
- CRVO 69.3M
- RDZN 79.4M
- IPO Year
- CRVO N/A
- RDZN N/A
- Fundamental
- Price
- CRVO $8.02
- RDZN $1.15
- Analyst Decision
- CRVO Strong Buy
- RDZN Strong Buy
- Analyst Count
- CRVO 8
- RDZN 2
- Target Price
- CRVO $25.57
- RDZN $5.00
- AVG Volume (30 Days)
- CRVO 209.3K
- RDZN 329.5K
- Earning Date
- CRVO 05-12-2025
- RDZN 07-01-2025
- Dividend Yield
- CRVO N/A
- RDZN N/A
- EPS Growth
- CRVO N/A
- RDZN N/A
- EPS
- CRVO N/A
- RDZN N/A
- Revenue
- CRVO $9,308,215.00
- RDZN $42,893,256.00
- Revenue This Year
- CRVO N/A
- RDZN $4.52
- Revenue Next Year
- CRVO N/A
- RDZN $53.72
- P/E Ratio
- CRVO N/A
- RDZN N/A
- Revenue Growth
- CRVO 15.14
- RDZN 2.79
- 52 Week Low
- CRVO $1.80
- RDZN $0.68
- 52 Week High
- CRVO $22.57
- RDZN $3.28
- Technical
- Relative Strength Index (RSI)
- CRVO 46.68
- RDZN 58.63
- Support Level
- CRVO $7.01
- RDZN $0.93
- Resistance Level
- CRVO $8.59
- RDZN $1.18
- Average True Range (ATR)
- CRVO 0.55
- RDZN 0.18
- MACD
- CRVO -0.12
- RDZN 0.02
- Stochastic Oscillator
- CRVO 55.56
- RDZN 68.92
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
About RDZN Roadzen Inc.
Roadzen Inc is an insurance technology company on a mission to transform global auto insurance powered by advanced AI. Its clients comprise major insurers, fleets, and carmakers to small fleets, brokers, and insurance agents that use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. The company's work in telematics and computer vision has earned recognition as an AI innovator by publications such as Forbes, Fortune, and Financial Express.